SRTA — Strata Critical Medical Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyAdventurousSmall CapNeutral

Annual cashflow statement for Strata Critical Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	15 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-39.3	-27.3	-56.1	-27.3	41.3
Depreciation
Deferred Taxes
Non-Cash Items	21.7	-14.8	24.8	22.2	-89.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1.62	-0.017	-6.74	-3.13	-9.08
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-21.6	-37.1	-32.3	-2.52	-48.9
Capital Expenditures	-0.521	-0.73	-2.11	-33	-11
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-316	80.1	19.2	32	80.8
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities	-317	79.3	17.1	-1.02	69.8
Financing Cash Flow Items	330	-1.17	-0.146	-5.68	-9.11
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	329	-1.08	-0.076	-5.76	-8.91
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-9.05	41.2	-15.4	-9.37	11.6